| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Abeona Therapeutics Inc. (ABEO) has 7 insiders with recent SEC Form 4 filings, including 6 buys and 0 sells. ABEO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.31M | $9.01M | -67,971 | |
| CFO | 493.6K | $3.41M | -24,880 | |
| VP | 428.0K | $2.95M | -12,050 | |
| Other | 290.6K | $2.01M | -12,606 | |
| Dir | 48.8K | $336.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 8, 2019 | Van Duyne Richard B | Director | Buy | 6,000 | $7.71 | $46,260.00 | New | |
| Apr 8, 2019 | Howell Stephen B. | Director | Buy | 4,000 | $7.77 | $31,080.00 | +5.3% | |
| Sep 20, 2016 | Wider Todd83 | Director | Buy | 5,000 | $5.48 | $27,400.00 | +7.1% | |
| Jul 31, 2015 | Ahn Mark J | Director | Buy | 18,182 | $5.50 | $100,001.00 | +5.6% | |
| Jul 31, 2015 | Wider Todd83 | Director | Buy | 20,000 | $5.50 | $110,000.00 | +40.0% | |
| Jan 26, 2015 | Ahn Mark J | Director | Buy | 25,000 | $4.00 | $100,000.00 | New |